Biotech | April 13, 2022
Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
Gomez joins Moderna from Dentsply Sirona, where he served as Executive Vice President & Chief Financial Officer since August 2019
Both companies have been selected for stand-by production by German government
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
The DRX-Compass helps navigate and accelerate towards superb performance with a solution that grows with its customers
Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities
Lidocaine and Prilocaine Cream USP, 2.5%/2.5% has an estimated market size of US $ 29 million for twelve months ending Dec. 2021 according to IQVIA
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Subscribe To Our Newsletter & Stay Updated
